BETHLEHEM, Pa.--(BUSINESS WIRE)--March 13, 2006--OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics and the manufacturer of the OraQuick(R) ADVANCE(TM) Rapid HIV-1/2 Antibody Test, today issued a statement following a meeting of the Blood Products Advisory Committee ("BPAC") of the Food and Drug Administration ("FDA"), held Friday, March 10, 2006, in Gaithersburg, MD.
